Microarrays for research into constitutional cytogenetics, rare disease and cancer

CytoSure arrays

For a number of years, microarrays have been considered the gold standard for research into copy number variation (CNV) and loss of heterozygosity (LOH) in constitutional, rare disease and cancer applications. The technique has enabled researchers to identify significantly more CNV and other structural alterations compared to traditional techniques such as karyotyping or MLPA.

The CytoSure™ range of microarrays provide a comprehensive choice of highly customisable array formats for research into constitutional and rare disease genetics, haematological cancer and pre-implantation genetic screening (PGS). Many of the CytoSure arrays are also highly targeted to allow detection of microdeletions and duplications at exon-level resolution.

Useful links

 

CytoSure™: For research use only; not for use in diagnostic procedures.